MK0767 and Sulfonylurea Combination Study (0767-027)
Status:
Terminated
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
This study will assess MK0767's ability vs. placebo to control blood glucose in patients with
type 2 diabetes and to gauge whether fasting blood glucose is lowered, blood fats are
improved, and insulin levels are impacted.
This is an early phase trial and some specific protocol information is in progress and not
publicly available at this time. (Full information is available to trial participants).